Concentric Capital Strategies’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,802
Closed -$1.05M 447
2026
Q1
$1.05M Sell
8,802
-14,568
-62% -$1.91M 0.09% 146
2025
Q4
$3.18M Sell
23,370
-21,598
-48% -$3.11M 0.15% 120
2025
Q3
$6.63M Sell
44,968
-40,814
-48% -$5.66M 0.3% 106
2025
Q2
$11.1M Buy
+85,782
New +$10.4M 0.49% 39
2025
Q1
Sell
-26,634
Closed -$3.09M 326
2024
Q4
$3.09M Buy
+26,634
New +$3.37M 0.14% 136
2024
Q2
Sell
-39,828
Closed -$5.15M 417
2024
Q1
$5.15M Buy
39,828
+23,033
+137% +$2.78M 0.29% 86
2023
Q4
$1.92M Buy
+16,795
New +$1.68M 0.22% 105
2023
Q2
Sell
-31,103
Closed -$3.26M 199
2023
Q1
$3.26M Buy
+31,103
New +$3.25M 1.07% 29

Other funds holding XYL

Concentric Capital Strategies's XYL Position: Q2 2026 in Review

Concentric Capital Strategies sold out of Xylem (XYL) in Q2 2026, closing a stake of 8,802 shares — an estimated $1.05M sold.

Concentric Capital Strategies first reported a position in XYL in Q1 2023 and held it in 8 quarters. The position peaked at $11.1M in Q2 2025. 1,090 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Concentric Capital Strategies reported no remaining Xylem position as of Q2 2026 after selling out during the quarter.
  • Concentric Capital Strategies sold 8,802 Xylem shares in Q2 2026, an estimated $1.05M.
  • Concentric Capital Strategies first reported a position in Xylem in Q1 2023 and held it in 8 quarters.
  • Concentric Capital Strategies's Xylem position peaked at $11.1M in Q2 2025.
  • 1,090 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Concentric Capital Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.